StonvexLoading…
StonvexCore line items from LMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $646.80M | $518.78M | $516.35M | $496.78M |
Operating Income | $49.45M | $38.62M | $29.28M | $12.01M |
Net Income | $39.06M | $30.88M | $20.75M | $6.80M |
EPS (Diluted) | $3.23 | $2.57 | $1.76 | $0.64 |
Total Assets | $381.13M | $352.13M | $304.44M | $294.56M |
Total Liabilities | $185.47M | $198.64M | $183.52M | $199.11M |
Cash & Equivalents | $11.35M | $44.93M | $59.83M | $36.00M |
Free Cash Flow OCF − CapEx | $41.89M | $29.26M | $55.10M | $34.38M |
Shares Outstanding | 11.63M | 11.27M | 11.00M | 10.29M |